Gene · 1487
Papers2,891
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,891
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring the role of microRNA-155 as a biomarker and regulatory modulator of target genes in metabolic syndrome. | SAGE Open Med | 2026 | 41777416 | PubTator, text mining | PubMed |
| Obstructive sleep apnea and lung cancer: molecular underpinnings and clinical translational prospects. | Front Cell Dev Biol | 2026 | 41768993 | PubTator, text mining | PubMed |
| Functional roles and mechanisms of circRNA-protein interactions in cancer progression and tumor immune regulation. | Front Immunol | 2026 | 41756268 | PubTator, text mining | PubMed |
Seeking Novel Personalized and Sex-Specific Strategies for the Prevention and Treatment of Heart Failure Based on the Assessment of β1-Adrenergic Receptor Desensitization: The Contribution to the HEAL ITALIA Project. | Curr Issues Mol Biol | 2026 | 41751396 | PubTator, text mining | PubMed |
| The Neuro-Bone Axis in Metastatic Progression: Innervation, Neuro-Immune-Osteoclast Crosstalk, and Therapeutic Opportunities. | Biology (Basel) | 2026 | 41744673 | PubTator, text mining | PubMed |
| Michael R. Bristow, MD, PhD: A Translational Pioneer Who Changed the Field of Heart Failure. | JACC Basic Transl Sci | 2026 | 41733290 | PubTator, text mining | PubMed |
| CCL11 promotes hepatocellular carcinoma recurrence after surgery by potentiating immunosuppressive CCR5 + CD206 + M2-like macrophages and promoting tumor invasiveness. | Cell Death Dis | 2026 | 41714328 | PubTator, text mining | PubMed |
| Phosphodiesterase 8 regulation of excitation-contraction coupling as a target for cardiovascular disease: is it my turn now? | Am J Physiol Heart Circ Physiol | 2026 | 41705944 | PubTator, text mining | PubMed |
| CTBP1 In Brain Development: A Novel Variant c.107G>C,p.(R36P) Leads to a Distinct Neurodevelopmental Disorder. | J Neurochem | 2026 | 41674141 | PubTator, text mining | PubMed |
| PALI1 enhances CtBP1/2 oligomerization and couples CtBP1/2 to PRC2. | Biochem Biophys Res Commun | 2026 | 41547303 | PubTator, text mining | PubMed |
| Introduction to Beta Agonists. | Vet Clin North Am Food Anim Pract | 2026 | 41530016 | PubTator, text mining | PubMed |
| CtBP1/2 oligomerization promotes G9a-Mediated transcriptional repression. | J Biol Chem | 2026 | 41419197 | PubTator, text mining | PubMed |
| Light-Based Molecular Tools to Precisely Monitor and Operate β-Adrenoceptors. | Med Res Rev | 2026 | 41121750 | PubTator, text mining | PubMed |
| Circulating Levels of miR-155 and CTBP1-AS2 as a Promising Biomarker for Early Detection of Diabetic Nephropathy. | Biochem Genet | 2026 | 40632189 | PubTator, text mining | PubMed |
Novel Insights into Pontocerebellar Hypoplasia Type 3: Discovery of a New Disease-causing PCLO Variant and Development of a CRISPR-generated Cell Model : Novel Insights into Pontocerebellar Hypoplasia Type 3. | Galen Med J | 2025 | 42038819 | PubTator, text mining | PubMed |
| Emerging opportunities in ROP therapy: from inhibiting pathological vessel growth to promoting physiological vascularization. | Front Med (Lausanne) | 2025 | 41601770 | PubTator, text mining | PubMed |
| Large-Scale Gene-Smoking Interactions and Fine Mapping Study Identifies Multiple Novel Blood Pressure Loci in over 1 Million Individuals. | medRxiv | 2025 | 41480028 | PubTator, text mining | PubMed |
| Subtype-Independent Dysregulation of the Notch Signaling Pathway and Its miRNA Regulators in Breast Cancer. | Biomedicines | 2025 | 41463075 | PubTator, text mining | PubMed |
| Isogenic iPSC-derived CTBP1 mutant neuronal cells exhibit neurodevelopmental defects. | Front Neurosci | 2025 | 41459558 | PubTator, text mining | PubMed |
| β2-adrenergic signaling controls neonatal respiratory syncytial virus infection by promoting viral clearance and airway protection. | Nat Commun | 2025 | 41413286 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1487/papers?page=2